Curaleaf Holdings (CURLF) Cash from Investing Activities (QoQ) (2019 - 2024)
Curaleaf Holdings (CURLF) Cash from Investing Activities (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6.25% |
| Sep 30, 2024 | -100.16% |
| Jun 30, 2024 | 199.77% |
| Mar 31, 2024 | -85,187.97% |
| Dec 31, 2023 | -2.02% |
| Sep 30, 2023 | -100.08% |
| Jun 30, 2023 | 199.86% |
| Mar 31, 2023 | -69,973.66% |
| Dec 31, 2022 | 9.41% |
| Dec 31, 2021 | -75.56% |
| Sep 30, 2021 | -2,154.19% |
| Jun 30, 2021 | 93.32% |
| Mar 31, 2021 | -17.69% |
| Dec 31, 2020 | -49,717.18% |
| Sep 30, 2020 | 99.93% |
| Jun 30, 2020 | -60.79% |
| Mar 31, 2020 | -76.11% |
| Dec 31, 2019 | -59,455.98% |